Richard Newitter
Stock Analyst at Truist Financial
(4.11)
# 1,569
Out of 4,357 analysts
979
Total ratings
45.7%
Success rate
6%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GKOS Glaukos | Maintained: Buy | n/a | $103.12 | - | 22 | May 29, 2026 | |
| BSX Boston Scientific | Maintained: Buy | n/a | $47.98 | - | 49 | May 28, 2026 | |
| PODD Insulet | Maintained: Buy | n/a | $148.13 | - | 13 | May 28, 2026 | |
| LNTH Lantheus Holdings | Maintained: Buy | n/a | $97.13 | - | 56 | May 26, 2026 | |
| BBNX Beta Bionics | Maintained: Buy | n/a | $12.80 | - | 12 | May 22, 2026 | |
| MDT Medtronic | Maintained: Hold | n/a | $73.98 | - | 47 | May 21, 2026 | |
| DXCM DexCom | Reiterated: Buy | n/a | $74.87 | - | 9 | May 15, 2026 | |
| SIBN SI-BONE | Reiterated: Buy | $20 → $18 | $13.87 | +29.78% | 15 | May 12, 2026 | |
| TMCI Treace Medical Concepts | Reiterated: Hold | $2 | $3.60 | -44.44% | 35 | May 12, 2026 | |
| TNDM Tandem Diabetes Care | Reiterated: Buy | $35 → $31 | $19.12 | +62.13% | 8 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $32.82 | - | 17 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $79.78 | - | 54 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $109.17 | - | 31 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $11.10 | +62.16% | 7 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $64 → $50 | $40.84 | +22.43% | 65 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $330 | $299.46 | +10.20% | 48 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $90.16 | - | 17 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $27.86 | - | 38 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $92 | $82.94 | +10.92% | 69 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $89 → $90 | $88.16 | +2.09% | 38 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $580 | $412.26 | +40.69% | 72 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $12 | $15.67 | -23.42% | 35 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $135 | $127.57 | +5.82% | 66 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $16.65 | +20.12% | 17 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $370 → $374 | $318.95 | +17.26% | 27 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $30.65 | - | 1 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $78.47 | - | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $26.87 | - | 1 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $232.64 | n/a | 1 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $10.90 | n/a | 1 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $26.20 | n/a | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $148 | $150.93 | n/a | 1 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.36 | n/a | 10 | Oct 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $5.24 | n/a | 3 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 55.60 → CHF 64.21 | $51.72 | n/a | 11 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $135.98 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $260 → $250 | $145.33 | n/a | 16 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $38.72 | n/a | 13 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $5.67 | n/a | 3 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $770 | $169.77 | n/a | 26 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $141 | $34.65 | n/a | 14 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $45 | $87.78 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $26.48 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $47 | $18.40 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $140 | $223.51 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $4.5 | $6.84 | n/a | 1 | Jul 15, 2016 |
Glaukos
May 29, 2026
Maintained: Buy
Price Target: n/a
Current: $103.12
Upside: -
Boston Scientific
May 28, 2026
Maintained: Buy
Price Target: n/a
Current: $47.98
Upside: -
Insulet
May 28, 2026
Maintained: Buy
Price Target: n/a
Current: $148.13
Upside: -
Lantheus Holdings
May 26, 2026
Maintained: Buy
Price Target: n/a
Current: $97.13
Upside: -
Beta Bionics
May 22, 2026
Maintained: Buy
Price Target: n/a
Current: $12.80
Upside: -
Medtronic
May 21, 2026
Maintained: Hold
Price Target: n/a
Current: $73.98
Upside: -
DexCom
May 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $74.87
Upside: -
SI-BONE
May 12, 2026
Reiterated: Buy
Price Target: $20 → $18
Current: $13.87
Upside: +29.78%
Treace Medical Concepts
May 12, 2026
Reiterated: Hold
Price Target: $2
Current: $3.60
Upside: -44.44%
Tandem Diabetes Care
May 11, 2026
Reiterated: Buy
Price Target: $35 → $31
Current: $19.12
Upside: +62.13%
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $32.82
Upside: -
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $79.78
Upside: -
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $109.17
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: $18
Current: $11.10
Upside: +62.16%
May 5, 2026
Maintained: Hold
Price Target: $64 → $50
Current: $40.84
Upside: +22.43%
May 4, 2026
Reiterated: Hold
Price Target: $330
Current: $299.46
Upside: +10.20%
May 1, 2026
Maintained: Buy
Price Target: n/a
Current: $90.16
Upside: -
Apr 30, 2026
Maintained: Buy
Price Target: n/a
Current: $27.86
Upside: -
Apr 29, 2026
Reiterated: Hold
Price Target: $92
Current: $82.94
Upside: +10.92%
Apr 24, 2026
Reiterated: Hold
Price Target: $89 → $90
Current: $88.16
Upside: +2.09%
Apr 22, 2026
Reiterated: Buy
Price Target: $580
Current: $412.26
Upside: +40.69%
Apr 15, 2026
Maintained: Hold
Price Target: $13 → $12
Current: $15.67
Upside: -23.42%
Mar 4, 2026
Reiterated: Hold
Price Target: $135
Current: $127.57
Upside: +5.82%
Mar 2, 2026
Reiterated: Hold
Price Target: $20
Current: $16.65
Upside: +20.12%
Jan 16, 2026
Downgraded: Hold
Price Target: $370 → $374
Current: $318.95
Upside: +17.26%
Jan 16, 2026
Maintained: Buy
Price Target: n/a
Current: $30.65
Upside: -
Jun 26, 2025
Maintained: Buy
Price Target: n/a
Current: $78.47
Upside: -
Jun 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $26.87
Upside: -
Oct 16, 2024
Rated: Buy
Price Target: n/a
Current: $232.64
Upside: n/a
Jun 20, 2024
Rated: Buy
Price Target: n/a
Current: $10.90
Upside: n/a
Apr 17, 2024
Reiterated: Buy
Price Target: n/a
Current: $26.20
Upside: n/a
Aug 22, 2023
Maintained: Hold
Price Target: $148
Current: $150.93
Upside: n/a
Oct 7, 2021
Maintained: Buy
Price Target: n/a
Current: $2.36
Upside: n/a
Sep 10, 2021
Initiated Coverage: Buy
Price Target: $20
Current: $5.24
Upside: n/a
Aug 17, 2021
Maintained: Hold
Price Target: CHF 55.60 → CHF 64.21
Current: $51.72
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: n/a
Current: $135.98
Upside: n/a
Aug 5, 2021
Rated: Hold
Price Target: $260 → $250
Current: $145.33
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $27
Current: $38.72
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $20
Current: $5.67
Upside: n/a
Jul 28, 2021
Rated: Buy
Price Target: $770
Current: $169.77
Upside: n/a
Jul 28, 2021
Rated: Hold
Price Target: $141
Current: $34.65
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: $45
Current: $87.78
Upside: n/a
Jul 15, 2016
Reiterated: Buy
Price Target: $20
Current: $26.48
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: $47
Current: $18.40
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: $140
Current: $223.51
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: $4.5
Current: $6.84
Upside: n/a